(Q42939581)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Impact of glucuronide interferences on therapeutic drug monitoring of posaconazole by tandem mass spectrometry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Michael Vogeser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Stephan Burghardt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Rita Vogelsberger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Karl J Lackner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

13 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

Clinical Chemistry and Laboratory Medicine

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1723-1731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Antifungal serum concentration monitoring: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Selective high-performance liquid chromatographic assay for itraconazole and hydroxyitraconazole in plasma from human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

A rapid HPLC method with fluorometric detection for determination of plasma itraconazole and hydroxy-itraconazole concentrations in cystic fibrosis children with allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Fast, fully automated analysis of voriconazole from serum by LC-LC-ESI-MS-MS with parallel column-switching technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Quantification of voriconazole in plasma by liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Posaconazole: a broad-spectrum triazole antifungal

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Use of high-performance liquid chromatographic and microbiological analyses for evaluating the presence or absence of active metabolites of the antifungal posaconazole in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Development and validation of a high-performance liquid chromatography assay for posaconazole utilizing solid-phase extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Determination of the antifungal agent posaconazole in human serum by HPLC with parallel column-switching technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Structural characterization of the oxidative degradation products of an antifungal agent SCH 56592 by LC-NMR and LC-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Disposition of posaconazole following single-dose oral administration in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

A routine method for the quantification of the novel antimycotic drug posaconazole in plasma using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

A high-throughput LC-MS/MS method for the quantitation of posaconazole in human plasma: Implementing fused core silica liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.333

21 January 2018

Identifiers

DOI

10.1515/CCLM.2010.333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20704538%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference